Sepoy-logo
No Result
View All Result
Saturday, December 2, 2023
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

CDC raises alarm: poor vaccine coverage fuels surge in meningococcal disease among HIV-infected individuals

Nicholas by Nicholas
June 19, 2023
in Health
0
CDC raises alarm: poor vaccine coverage fuels surge in meningococcal disease among HIV-infected individuals

In a recent Morbidity and Mortality Weekly Report (MMWR), the United States Centers for Disease Control and Prevention (US-CDC) presented preliminary data showing an increase in meningococcal disease among human immunodeficiency virus (HIV)-infected individuals in the US in 2022. 

Study: Notes from the Field: Increase in Meningococcal Disease Among Persons with HIV — United States, 2022. Image Credit: NovikovAleksey/Shutterstock.comStudy: Notes from the Field: Increase in Meningococcal Disease Among Persons with HIV — United States, 2022. Image Credit: NovikovAleksey/Shutterstock.com

Background

Neisseria meningitides cause meningococcal disease, an illness typically manifesting as meningitis or meningococcemia. Some of the most frequent and shared signs and symptoms of meningitis and meningococcemia include fever, chills, headache, stiff neck, fatigue, and severe pain.

The US Advisory Committee on Immunization Practices (ACIP) recommended the use of a quadrivalent, two-dose series of meningococcal conjugate vaccination (MenACWY) for the HIV-infected population of the country.

Subsequently, in 2016, the US incorporated it into the immunization schedule. Likewise, they recommend its routine use for adolescents and persons at a higher risk for meningococcal disease. 

However, an analysis of administrative claims data undertaken between January 2016 and March 2018 showed that vaccine coverage for MenACWY remained low among HIV-infected individuals, with only 16.3% receiving one or more than one dose of the MenACWY vaccine within two years of diagnosis. 

The Notifiable Diseases Surveillance System (NDSS), with extra epidemiologic data and isolates retrieved through enhanced surveillance, reported all meningococcal disease cases in the US.

They used whole genome sequencing (WGS) to characterize and determine serogroup and molecular typing information from these isolates, and the CDC reviewed this activity per the applicable federal law and policy.

Observations

Based on preliminary data, between 2017 and 2021, five to 15 meningococcal disease cases occurred among HIV-infected people annually, representing 1.5% to 4.3% of all disease cases.

In 2022, this case number surged to 29, representing 9.8% of all cases in HIV-infected people annually; however, these cases might increase further when data reporting is complete.

The CDC found that only one person among all 29 meningococcal disease cases in the HIV-infected population in 2022 had received the MenACWY vaccine, but even his dosage schedule was unknown. The remaining 22 people had not received the MenACWY vaccine, while six had unknown MenACWY vaccination history. 

Furthermore, 15/29 cases occurred in men who have sex with men (MSM) during a large serogroup C outbreak. Compared to the 2017–2021 period, in 2022, even after excluding MSM outbreak-associated cases, the meningococcal disease cases remained higher among HIV-infected people (four to eight vs. 14).

Of the remaining 14 cases unrelated to the outbreak, nine were due to a single N. meningitidis strain identified across three US states with no connections among all identified cases. 

Notably, eight of these nine cases occurred in people of African origin (Black Americans) and seven among MSM. CDC identified it as serogroup Y clonal complex CC174 sequence type ST-1466. The rest five cases had no epidemiologic connections and did not cluster geographically.

Conclusions

The current CDC report highlighted that the MenACWY vaccine coverage among the HIV-infected population of the US was low till 2022.

Thus, meningococcal disease cases increased in this population. The report raises the need to encourage HIV-infected people to be up to date with MenACWY and other vaccinations per ACIP recommendations.

Healthcare providers should help achieve these goals while maintaining a high index of suspicion for meningococcal disease among the HIV-infected U.S. population.

Screening of patients with meningococcal disease for HIV is vital. In fact, the CDC highly recommends screening all people for HIV. 

READ ALSO

18-month meditation program improves psychological wellbeing in seniors

Adverse childhood experiences may increase the odds of muscle dysmorphia in young people

Tags: FatigueFeverHeadacheHIVImmunizationImmunodeficiencyMeningitisMeningococcal DiseaseMeningococcemiaMortalityNeckPainVaccineVirus

Related Posts

18-month meditation program improves psychological wellbeing in seniors
Health

18-month meditation program improves psychological wellbeing in seniors

December 1, 2023
Adverse childhood experiences may increase the odds of muscle dysmorphia in young people
Health

Adverse childhood experiences may increase the odds of muscle dysmorphia in young people

December 1, 2023
Brain peptide identified as key player in heavy alcohol drinking
Health

Brain peptide identified as key player in heavy alcohol drinking

December 1, 2023
Explosive Desantis-Newsom debate reflects nation’s culture wars
Health

Explosive Desantis-Newsom debate reflects nation’s culture wars

December 1, 2023
Study reveals G6PD deficiency linked to higher ADHD risk and increased use of stimulant medications
Health

Study reveals G6PD deficiency linked to higher ADHD risk and increased use of stimulant medications

December 1, 2023
Social media posts can negatively impact perceptions of mental health treatment
Health

Social media posts can negatively impact perceptions of mental health treatment

December 1, 2023
Next Post
Inflation: the markets are too “optimistic” according to Goldman Sachs

Inflation: the markets are too “optimistic” according to Goldman Sachs

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

POPULAR NEWS

Roblox Is Unbreakable Trello Is this safe?

Roblox Is Unbreakable Trello Is this safe?

November 4, 2022
Discord Registered Games  Discord Registered Gaming You need to join the Club

Discord Registered Games Discord Registered Gaming You need to join the Club

November 4, 2022
How To Chose the Right Data Analytics Program

How To Chose the Right Data Analytics Program

November 4, 2022
Heavy explosion on market square in Halle – three injured

Heavy explosion on market square in Halle – three injured

November 4, 2022

Shivon Zilis Wiki, Height, Age, Boyfriend, Husband, Family, Biography & More

July 11, 2022

EDITOR'S PICK

Partnership Announcement: MBC Group and First General Property Restoration Services to expand EcoClaim® Certification

Partnership Announcement: MBC Group and First General Property Restoration Services to expand EcoClaim® Certification

November 29, 2022

FM Global announces leader of global middle-market division

September 8, 2022

Children are less fit and more obese than ever before, study says

August 5, 2022
What are the eye complications associated with monkeypox infection?

What are the eye complications associated with monkeypox infection?

November 9, 2022

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: [email protected]

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Unique Housewarming Gift Ideas to Warm Hearts and Homes in Style!
  • Lindner: Aussetzen der Schuldenbremse ist nicht ausgeschlossen
  • Beginners Guide to Understanding the Salary Calculator

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net

x